Twin Focus Capital Partners, LLC Cullinan Oncology, Inc. Transaction History
Twin Focus Capital Partners, LLC
- $625 Million
- Q3 2024
A detailed history of Twin Focus Capital Partners, LLC transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Twin Focus Capital Partners, LLC holds 595,489 shares of CGEM stock, worth $8.01 Million. This represents 1.59% of its overall portfolio holdings.
Number of Shares
595,489
Previous 595,489
-0.0%
Holding current value
$8.01 Million
Previous $10.4 Million
4.02%
% of portfolio
1.59%
Previous 1.67%
Shares
1 transactions
Others Institutions Holding CGEM
# of Institutions
146Shares Held
67.6MCall Options Held
612KPut Options Held
118K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$103 Million19.97% of portfolio
-
Bvf Inc San Francisco, CA5.75MShares$77.3 Million3.06% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$47.8 Million0.0% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$45.9 Million15.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.28MShares$44.1 Million1.02% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $613M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...